The plasma carboxypeptidases and the regulation of the plasminogen system.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Trends in cardiovascular medicine

• Publication date

  1997-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1050-1738(97)00012-1PMID 21235867
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex*

  1996cited by this paper
• The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent.

  1996cited by this paper
• Impaired wound healing in mice with a disrupted plasminogen gene

  1996cited by this paper
• Characterization of Cellular Binding Sites and Interactive Regions within Reactants Required for Enhancement of Plasminogen Activation by tPA on the Surface of Leukocytic Cells

  1996cited by this paper
• Inducible carboxypeptidase activity. A role in clot lysis in vivo.

  1996cited by this paper
• The gene for human carboxypeptidase U (CPU)--a proposed novel regulator of plasminogen activation--maps to 13q14.11.

  1996cited by this paper
• Gene targeting and gene transfer studies of the plaeminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis

  1995cited by this paper
• Plasma carboxypeptidases as regulators of the plasminogen system.

  1995cited by this paper
• Activation and characterization of procarboxypeptidase B from human plasma.

  1995cited by this paper
• Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.

  1995cited by this paper
• The cell biology of the plasminogen system

  1995cited by this paper
• Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators.

  1995cited by this paper
• Human carboxypeptidase N: lysine carboxypeptidase.

  1995cited by this paper
• Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor (*)

  1995cited by this paper
• Capturing host plasmin(ogen): a common mechanism for invasive pathogens?

  1994cited by this paper
• The physiological aspects of fibrinolysis.

  1994cited by this paper
• Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen.

  1994cited by this paper
• The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation.

  1993cited by this paper
• Extracellular Matrix Degradation

  1991cited by this paper
• Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin.

  1991cited by this paper
• Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma.

  1991cited by this paper
• Cell Biology of Extracellular Matrix

  1991cited by this paper
• The plasminogen activator/plasmin system.

  1991cited by this paper
• Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor.

  1991cited by this paper
• Fibrinolytic Therapy: Biochemical Mechanisms

  1991cited by this paper
• The activated protein C-mediated enhancement of tissue-type plasminogen activator-induced fibrinolysis in a cell-free system.

  1990cited by this paper
• Characterisation of a Carboxypeptidase in Human Serum Distinct from Carboxypeptidase N

  1989cited by this paper
• Structure of human carboxypeptidase N (kininase I).

  1989cited by this paper
• Cell-associated plasminogen activation: regulation and physiological functions.

  1988cited by this paper
• Control of human plasminogen activation.

  1988cited by this paper
• Basic carboxypeptidases: regulators of peptide hormone activity.

  1988cited by this paper
• The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type

  1986cited by this paper
• Proteolytic Enzymes in Cancer Invasion and Metastasis

  1986cited by this paper
• Whole blood clot lysis: in vitro modulation by activated protein C.

  1985cited by this paper
• Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

  1982cited by this paper
• Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of laminin.

  1981cited by this paper
• The release of heparin binding peptides from platelet thrombospondin by proteolytic action of thrombin, plasmin and trypsin.

  1981cited by this paper
• On the Regulation and Control of Fibrinolysis

  1980cited by this paper
• Molecular mechanism of physiological fibrinolysis

  1978cited by this paper
• ENZYMATIC STUDIES ON BRADYKININ AND SIMILAR PEPTIDES

  1963cited by this paper

• Impact of Vitamin D Status Correction on Serum Lipid Profile, Carboxypeptidase N and Nitric Oxide Levels in Saudi Adults

  2023cites this paper
• Novel molecular plasma signatures on cardiovascular disease can stratify patients throughout life.

  2020cites this paper
• Sex-specific effect of CPB2 Ala147Thr but not Thr325Ile variants on the risk of venous thrombosis: A comprehensive meta-analysis

  2017cites this paper
• Association between thrombin-activatable fibrinolysis inhibitor gene polymorphisms and venous thrombosis risk: a meta-analysis

  2016cites this paper
• Identification of Thrombosis Modifier Genes Using ENU Mutagenesis in the Mouse.

  2016cites this paper
• Lysine Carboxypeptidase/Carboxypeptidase N

  2013cites this paper
• Binding of carboxypeptidase N to fibrinogen and fibrin.

  2012cites this paper
• Arginine and lysine as products of basic carboxypeptidase activity associated with fibrinolysis

  2012cites this paper
• The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study 1

  2009cites this paper
• Physiologie der Blutgerinnung und Fibrinolyse

  2008cites this paper
• [Physiology of blood coagulation and fibrinolysis: biochemistry].

  2008cites this paper
• Binding of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) to Plasminogen May Play a Role in the Fibrinolytic Pathway

  2008cites this paper
• Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain.

  2007cites this paper
• Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis

  2007cites this paper
• Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator.

  2007cites this paper
• Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N.

  2005cites this paper
• Carboxypeptidase U (TAFIa): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease

  2005cites this paper
• Budd-Chiari Syndrome: New insights in Pathogenesis, Management and Prognosis

  2004cites this paper
• 247 – Lysine carboxypeptidase

  2004cites this paper
• Biochemie und Physiologie der Blutgerinnung und Fibrinolyse

  2004cites this paper
• Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris

  2003cites this paper
• Mutations in the Substrate Binding Site of Thrombin-activatable Fibrinolysis Inhibitor (TAFI) Alter Its Substrate Specificity*

  2003cites this paper
• Thrombin Avtivable Fibrinolysis Inhibitor in Venous and Arterial Thrombosis

  2003cites this paper
• Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life.

  2002cites this paper
• Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice.

  2002cites this paper
• Basic principles in thrombolysis: regulatory role of plasminogen.

  2001cites this paper
• Fast Homogeneous Assay for Plasma Procarboxypeptidase U

  2001cites this paper
• TAFI Meets the Sticky Ends

  2001cites this paper
• Carboxypeptidase U at the interface between coagulation and fibrinolysis.

  2001cites this paper
• Antiphospholipid antibodies and the coagulation cascade.

  2001cites this paper
• Inhibition of Fibrinolysis by Lipoprotein(a)

  2001cites this paper
• arboxypeptidase U at the Interface Between Coagulation and Fibrinolysis

  2001cites this paper
• Molecular transport during fibrin clot lysis

  2000cites this paper
• An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.

  2000cites this paper
• Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis.

  2000influential citation
• Characterization of Plasmin-mediated Activation of Plasma Procarboxypeptidase B

  1999cites this paper